Publications by authors named "Quanxing Ni"

Claim this Profile
[
[Corrigendum] RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.
Zi-Hao Qi, Hua-Xiang Xu, Shi-Rong Zhang, Jin-Zhi Xu, Shuo Li, Quan-Xing Ni

Int J Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor potential of polyamines in cancer.
He Liu, Yi Liu, Xinyue Wang, Zhiwen Xiao, Quanxing Ni

Acta Biochim Biophys Sin (Shanghai)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Cancer: An Exocrine Tumor With Endocrine Characteristics.
Xinzhe Zhu, Zhiwen Xiao, He Liu, Pin Zhang, Shengming Deng, Quanxing Ni

Ann Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.
Zhiwen Xiao, Huaxiang Xu, Jonathan R Strosberg, Renquan Lu, Xinzhe Zhu, Quanxing Ni

Int J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutamine deprivation induces ferroptosis in pancreatic cancer cells.
Zhiwen Xiao, Shengming Deng, He Liu, Ruijie Wang, Yu Liu, Quanxing Ni

Acta Biochim Biophys Sin (Shanghai)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients.
Xinzhe Zhu, Huaxiang Xu, Zhiwen Xiao, He Liu, Quanxing Ni

Endocrine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer.
Chen Liu, Shengming Deng, Zhiwen Xiao, Renquan Lu, He Cheng, Quanxing Ni

Discov Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasms.
Pin Zhang, Zhiwen Xiao, Huaxiang Xu, Xinzhe Zhu, Lei Wang, Quanxing Ni

Endocrine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors.
Heli Gao, Jia Dong, Wuhu Zhang, Huaxiang Xu, Longyun Ye, Quanxing Ni

Endocr Pract· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.
Guopei Luo, Kaizhou Jin, Shengming Deng, He Cheng, Zhiyao Fan, Quanxing Ni

Biochim Biophys Acta Rev Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour.
Yitao Gong, Zhiyao Fan, Pin Zhang, Yunzhen Qian, Qiuyi Huang, Quanxing Ni

Endocrine· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma.
Yitao Gong, Yunzhen Qian, Guopei Luo, Yu Liu, Ruijie Wang, Quanxing Ni

World J Surg Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas.
Shengming Deng, Zhiyao Fan, Yitao Gong, He Cheng, Kaizhou Jin, Quanxing Ni

Exp Ther Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy.
Chen Liu, He Cheng, Kaizhou Jin, Zhiyao Fan, Yitao Gong, Quanxing Ni

Cancer Control· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Yunzhen Qian, Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Quanxing Ni

J Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active surveillance in metastatic pancreatic neuroendocrine tumors: A 20-year single-institutional experience.
He-Li Gao, Wen-Quan Wang, Hua-Xiang Xu, Chun-Tao Wu, Hao Li, Quan-Xing Ni

World J Clin Cases· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of distal pancreatic cancers controlled by stage.
Guopei Luo, Kaizhou Jin, He Cheng, Meng Guo, Yitao Gong, Quanxing Ni

Exp Ther Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients.
Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Yunzhen Qian, Quanxing Ni

Cancer Manag Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes Is Associated With the Metastasis of Pancreatic Neuroendocrine Tumors.
Zhiyao Fan, Yitao Gong, Qiuyi Huang, Chao Yang, He Cheng, Quanxing Ni

Pancreas· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma.
Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Yunzhen Qian, Quanxing Ni

Pancreatology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lewis antigen‑negative pancreatic cancer: An aggressive subgroup.
Chen Liu, Shengming Deng, Kaizhou Jin, Yitao Gong, He Cheng, Quanxing Ni

Int J Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer.
Shuai-Shuai Xu, Shuo Li, Hua-Xiang Xu, Hao Li, Chun-Tao Wu, Quan-Xing Ni

World J Gastroenterol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine.
Liu Wensheng, Zhang Bo, Hu Qiangsheng, Xu Wenyan, Ji Shunrong, Ni Quanxing

Cancer Cell Int· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer.
Zhiyao Fan, Kun Fan, Yitao Gong, Qiuyi Huang, Chao Yang, Quanxing Ni

Cancer Manag Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis.
Yiyin Zhang, Jin Xu, Jie Hua, Jiang Liu, Chen Liang, Quanxing Ni

J Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis